Switch to:
Also traded in: Germany, Switzerland, UK

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.74
CERN's Cash to Debt is ranked lower than
75% of the 1796 Companies
in the Global Health Information Services industry.

( Industry Median: 7.51 vs. CERN: 0.74 )
Ranked among companies with meaningful Cash to Debt only.
CERN' s Cash to Debt Range Over the Past 10 Years
Min: 0.62  Med: 1.49 Max: 10.9
Current: 0.74
0.62
10.9
Equity to Asset 0.70
CERN's Equity to Asset is ranked higher than
65% of the 1710 Companies
in the Global Health Information Services industry.

( Industry Median: 0.61 vs. CERN: 0.70 )
Ranked among companies with meaningful Equity to Asset only.
CERN' s Equity to Asset Range Over the Past 10 Years
Min: 0.55  Med: 0.69 Max: 0.79
Current: 0.7
0.55
0.79
F-Score: 6
Z-Score: 9.32
M-Score: -2.07
WACC vs ROIC
10.49%
16.15%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 9/10

vs
industry
vs
history
Operating margin (%) 18.18
CERN's Operating margin (%) is ranked higher than
85% of the 1752 Companies
in the Global Health Information Services industry.

( Industry Median: 4.69 vs. CERN: 18.18 )
Ranked among companies with meaningful Operating margin (%) only.
CERN' s Operating margin (%) Range Over the Past 10 Years
Min: 12.06  Med: 18.45 Max: 22.43
Current: 18.18
12.06
22.43
Net-margin (%) 12.48
CERN's Net-margin (%) is ranked higher than
80% of the 1753 Companies
in the Global Health Information Services industry.

( Industry Median: 3.26 vs. CERN: 12.48 )
Ranked among companies with meaningful Net-margin (%) only.
CERN' s Net-margin (%) Range Over the Past 10 Years
Min: 7.43  Med: 12.20 Max: 15.44
Current: 12.48
7.43
15.44
ROE (%) 14.18
CERN's ROE (%) is ranked higher than
73% of the 1700 Companies
in the Global Health Information Services industry.

( Industry Median: 6.17 vs. CERN: 14.18 )
Ranked among companies with meaningful ROE (%) only.
CERN' s ROE (%) Range Over the Past 10 Years
Min: 12.37  Med: 13.50 Max: 15.61
Current: 14.18
12.37
15.61
ROA (%) 10.31
CERN's ROA (%) is ranked higher than
81% of the 1801 Companies
in the Global Health Information Services industry.

( Industry Median: 3.07 vs. CERN: 10.31 )
Ranked among companies with meaningful ROA (%) only.
CERN' s ROA (%) Range Over the Past 10 Years
Min: 7.55  Med: 10.30 Max: 12.18
Current: 10.31
7.55
12.18
ROC (Joel Greenblatt) (%) 51.14
CERN's ROC (Joel Greenblatt) (%) is ranked higher than
64% of the 1768 Companies
in the Global Health Information Services industry.

( Industry Median: 22.73 vs. CERN: 51.14 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
CERN' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 35.73  Med: 44.79 Max: 73.16
Current: 51.14
35.73
73.16
Revenue Growth (3Y)(%) 15.30
CERN's Revenue Growth (3Y)(%) is ranked higher than
79% of the 1357 Companies
in the Global Health Information Services industry.

( Industry Median: 4.90 vs. CERN: 15.30 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
CERN' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 5.8  Med: 14.60 Max: 29.5
Current: 15.3
5.8
29.5
EBITDA Growth (3Y)(%) 15.90
CERN's EBITDA Growth (3Y)(%) is ranked higher than
67% of the 1100 Companies
in the Global Health Information Services industry.

( Industry Median: 6.90 vs. CERN: 15.90 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
CERN' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -12.1  Med: 16.45 Max: 71
Current: 15.9
-12.1
71
EPS Growth (3Y)(%) 19.40
CERN's EPS Growth (3Y)(%) is ranked higher than
69% of the 1024 Companies
in the Global Health Information Services industry.

( Industry Median: 5.80 vs. CERN: 19.40 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
CERN' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -68.2  Med: 20.55 Max: 448.5
Current: 19.4
-68.2
448.5
» CERN's 10-Y Financials

Financials (Next Earnings Date: 2016-02-16)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2015

CERN Guru Trades in Q1 2015

Paul Tudor Jones 6,700 sh (New)
Jim Simons 15,500 sh (New)
Ray Dalio 186,470 sh (+265.84%)
Frank Sands 17,629,838 sh (+0.33%)
PRIMECAP Management 20,000 sh (unchged)
Ron Baron 417,460 sh (-1.16%)
Jeremy Grantham 339,759 sh (-1.36%)
Vanguard Health Care Fund 12,499,290 sh (-2.67%)
Manning & Napier Advisors, Inc 8,543,652 sh (-4.39%)
Murray Stahl 11,519 sh (-11.97%)
Jim Chanos 92,240 sh (-28.58%)
Jim Chanos 92,240 sh (-28.58%)
» More
Q2 2015

CERN Guru Trades in Q2 2015

Jim Simons 203,004 sh (+1209.70%)
Paul Tudor Jones 8,510 sh (+27.01%)
Murray Stahl 13,194 sh (+14.54%)
Jim Chanos 104,244 sh (+13.01%)
Jim Chanos 104,244 sh (+13.01%)
Vanguard Health Care Fund 13,784,330 sh (+10.28%)
PRIMECAP Management 20,000 sh (unchged)
Jeremy Grantham 333,759 sh (-1.77%)
Ron Baron 387,243 sh (-7.24%)
Frank Sands 14,935,655 sh (-15.28%)
Manning & Napier Advisors, Inc 5,202,108 sh (-39.11%)
Ray Dalio 68,777 sh (-63.12%)
» More
Q3 2015

CERN Guru Trades in Q3 2015

Pioneer Investments 14,418 sh (New)
Jim Simons 253,404 sh (+24.83%)
Vanguard Health Care Fund 15,849,330 sh (+14.98%)
Paul Tudor Jones 150,000 sh (unchged)
Manning & Napier Advisors, Inc 5,202,108 sh (unchged)
PRIMECAP Management 20,000 sh (unchged)
Jim Chanos Sold Out
Frank Sands 14,665,256 sh (-1.81%)
Manning & Napier Advisors, Inc 5,093,271 sh (-2.09%)
Murray Stahl 11,210 sh (-15.04%)
Ron Baron 277,124 sh (-28.44%)
Paul Tudor Jones 5,100 sh (-40.07%)
Ray Dalio 37,477 sh (-45.51%)
Jeremy Grantham 178,069 sh (-46.65%)
» More
Q4 2015

CERN Guru Trades in Q4 2015

Vanguard Health Care Fund 16,424,330 sh (+3.63%)
» More
» Details

Insider Trades

Latest Guru Trades with CERN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about Cerner Corp

Stocks That Lost Their Positions in Jim Chanos' Portfolio Guru sold stakes in Cerner, SunEdison and Akamai Technologies in the 3rd quarter
Jim Chanos is president and founder of Kynikos Associates LP., an employee-owned investment manager, and invests in public equity and fixed income markets across the globe. The hedge fund has 54 stocks with a total value of $248 milion. Read more...
Manning & Napier Trades in Each of its Top 10 Stakes in First Quarter
On its website, Rochester, New York-based Manning & Napier speaks of its “independent, opportunistic style” that helps its clients meet their financial objectives. In its 45-year existence, Manning & Napier contends that “to survive and grow in a difficult economic time, we had to add real value for our clients.” Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 39.20
CERN's P/E(ttm) is ranked lower than
72% of the 1701 Companies
in the Global Health Information Services industry.

( Industry Median: 24.40 vs. CERN: 39.20 )
Ranked among companies with meaningful P/E(ttm) only.
CERN' s P/E(ttm) Range Over the Past 10 Years
Min: 14.89  Med: 38.01 Max: 54.89
Current: 39.2
14.89
54.89
Forward P/E 21.55
CERN's Forward P/E is ranked lower than
63% of the 952 Companies
in the Global Health Information Services industry.

( Industry Median: 17.24 vs. CERN: 21.55 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 39.20
CERN's PE(NRI) is ranked lower than
69% of the 1273 Companies
in the Global Health Information Services industry.

( Industry Median: 24.83 vs. CERN: 39.20 )
Ranked among companies with meaningful PE(NRI) only.
CERN' s PE(NRI) Range Over the Past 10 Years
Min: 14.79  Med: 38.43 Max: 54.94
Current: 39.2
14.79
54.94
P/B 5.20
CERN's P/B is ranked lower than
78% of the 2318 Companies
in the Global Health Information Services industry.

( Industry Median: 2.46 vs. CERN: 5.20 )
Ranked among companies with meaningful P/B only.
CERN' s P/B Range Over the Past 10 Years
Min: 2.05  Med: 4.51 Max: 6.93
Current: 5.2
2.05
6.93
P/S 4.92
CERN's P/S is ranked lower than
86% of the 2318 Companies
in the Global Health Information Services industry.

( Industry Median: 1.65 vs. CERN: 4.92 )
Ranked among companies with meaningful P/S only.
CERN' s P/S Range Over the Past 10 Years
Min: 1.67  Med: 4.17 Max: 7.51
Current: 4.92
1.67
7.51
PFCF 76.98
CERN's PFCF is ranked lower than
88% of the 1250 Companies
in the Global Health Information Services industry.

( Industry Median: 23.33 vs. CERN: 76.98 )
Ranked among companies with meaningful PFCF only.
CERN' s PFCF Range Over the Past 10 Years
Min: 15.22  Med: 45.42 Max: 1431
Current: 76.98
15.22
1431
POCF 25.14
CERN's POCF is ranked lower than
68% of the 1563 Companies
in the Global Health Information Services industry.

( Industry Median: 17.23 vs. CERN: 25.14 )
Ranked among companies with meaningful POCF only.
CERN' s POCF Range Over the Past 10 Years
Min: 9.18  Med: 19.63 Max: 33.35
Current: 25.14
9.18
33.35
EV-to-EBIT 25.99
CERN's EV-to-EBIT is ranked lower than
69% of the 1781 Companies
in the Global Health Information Services industry.

( Industry Median: 16.91 vs. CERN: 25.99 )
Ranked among companies with meaningful EV-to-EBIT only.
CERN' s EV-to-EBIT Range Over the Past 10 Years
Min: 9  Med: 23.10 Max: 35.6
Current: 25.99
9
35.6
EV-to-EBITDA 16.92
CERN's EV-to-EBITDA is ranked lower than
65% of the 1916 Companies
in the Global Health Information Services industry.

( Industry Median: 12.27 vs. CERN: 16.92 )
Ranked among companies with meaningful EV-to-EBITDA only.
CERN' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.7  Med: 14.10 Max: 24.6
Current: 16.92
5.7
24.6
PEG 2.51
CERN's PEG is ranked lower than
60% of the 537 Companies
in the Global Health Information Services industry.

( Industry Median: 1.80 vs. CERN: 2.51 )
Ranked among companies with meaningful PEG only.
CERN' s PEG Range Over the Past 10 Years
Min: 0.82  Med: 2.36 Max: 3.7
Current: 2.51
0.82
3.7
Shiller P/E 66.87
CERN's Shiller P/E is ranked lower than
77% of the 403 Companies
in the Global Health Information Services industry.

( Industry Median: 35.58 vs. CERN: 66.87 )
Ranked among companies with meaningful Shiller P/E only.
CERN' s Shiller P/E Range Over the Past 10 Years
Min: 34.87  Med: 73.13 Max: 95.51
Current: 66.87
34.87
95.51
Current Ratio 2.15
CERN's Current Ratio is ranked higher than
54% of the 1732 Companies
in the Global Health Information Services industry.

( Industry Median: 2.00 vs. CERN: 2.15 )
Ranked among companies with meaningful Current Ratio only.
CERN' s Current Ratio Range Over the Past 10 Years
Min: 1.79  Med: 2.83 Max: 5.22
Current: 2.15
1.79
5.22
Quick Ratio 2.12
CERN's Quick Ratio is ranked higher than
57% of the 1732 Companies
in the Global Health Information Services industry.

( Industry Median: 1.88 vs. CERN: 2.12 )
Ranked among companies with meaningful Quick Ratio only.
CERN' s Quick Ratio Range Over the Past 10 Years
Min: 1.75  Med: 2.80 Max: 5.14
Current: 2.12
1.75
5.14
Days Inventory 12.83
CERN's Days Inventory is ranked higher than
57% of the 1028 Companies
in the Global Health Information Services industry.

( Industry Median: 17.91 vs. CERN: 12.83 )
Ranked among companies with meaningful Days Inventory only.
CERN' s Days Inventory Range Over the Past 10 Years
Min: 12.15  Med: 14.15 Max: 19.85
Current: 12.83
12.15
19.85
Days Sales Outstanding 88.47
CERN's Days Sales Outstanding is ranked lower than
67% of the 1428 Companies
in the Global Health Information Services industry.

( Industry Median: 68.53 vs. CERN: 88.47 )
Ranked among companies with meaningful Days Sales Outstanding only.
CERN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 66.04  Med: 94.00 Max: 102.12
Current: 88.47
66.04
102.12
Days Payable 104.75
CERN's Days Payable is ranked higher than
80% of the 1300 Companies
in the Global Health Information Services industry.

( Industry Median: 44.65 vs. CERN: 104.75 )
Ranked among companies with meaningful Days Payable only.
CERN' s Days Payable Range Over the Past 10 Years
Min: 47.89  Med: 95.25 Max: 115.48
Current: 104.75
47.89
115.48

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 167.11
CERN's Price/Net Current Asset Value is ranked lower than
96% of the 1518 Companies
in the Global Health Information Services industry.

( Industry Median: 6.53 vs. CERN: 167.11 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
CERN' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 3.42  Med: 15.61 Max: 171.31
Current: 167.11
3.42
171.31
Price/Tangible Book 11.12
CERN's Price/Tangible Book is ranked lower than
78% of the 1820 Companies
in the Global Health Information Services industry.

( Industry Median: 4.00 vs. CERN: 11.12 )
Ranked among companies with meaningful Price/Tangible Book only.
CERN' s Price/Tangible Book Range Over the Past 10 Years
Min: 1.59  Med: 4.98 Max: 14.36
Current: 11.12
1.59
14.36
Price/Projected FCF 2.64
CERN's Price/Projected FCF is ranked lower than
73% of the 1241 Companies
in the Global Health Information Services industry.

( Industry Median: 1.58 vs. CERN: 2.64 )
Ranked among companies with meaningful Price/Projected FCF only.
CERN' s Price/Projected FCF Range Over the Past 10 Years
Min: 1.33  Med: 2.69 Max: 4.7
Current: 2.64
1.33
4.7
Price/DCF (Earnings Based) 1.38
CERN's Price/DCF (Earnings Based) is ranked higher than
53% of the 239 Companies
in the Global Health Information Services industry.

( Industry Median: 1.49 vs. CERN: 1.38 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.18
CERN's Price/Median PS Value is ranked lower than
56% of the 2119 Companies
in the Global Health Information Services industry.

( Industry Median: 1.07 vs. CERN: 1.18 )
Ranked among companies with meaningful Price/Median PS Value only.
CERN' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.26  Med: 0.75 Max: 1.71
Current: 1.18
0.26
1.71
Price/Peter Lynch Fair Value 2.58
CERN's Price/Peter Lynch Fair Value is ranked lower than
69% of the 549 Companies
in the Global Health Information Services industry.

( Industry Median: 1.75 vs. CERN: 2.58 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
CERN' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.45  Med: 1.85 Max: 3.32
Current: 2.58
0.45
3.32
Price/Graham Number 4.36
CERN's Price/Graham Number is ranked lower than
73% of the 1333 Companies
in the Global Health Information Services industry.

( Industry Median: 2.19 vs. CERN: 4.36 )
Ranked among companies with meaningful Price/Graham Number only.
CERN' s Price/Graham Number Range Over the Past 10 Years
Min: 1.37  Med: 2.90 Max: 16.4
Current: 4.36
1.37
16.4
Earnings Yield (Greenblatt) (%) 3.84
CERN's Earnings Yield (Greenblatt) (%) is ranked higher than
56% of the 1732 Companies
in the Global Health Information Services industry.

( Industry Median: 2.70 vs. CERN: 3.84 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
CERN' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 2.8  Med: 4.30 Max: 11.1
Current: 3.84
2.8
11.1
Forward Rate of Return (Yacktman) (%) 16.86
CERN's Forward Rate of Return (Yacktman) (%) is ranked higher than
68% of the 688 Companies
in the Global Health Information Services industry.

( Industry Median: 10.58 vs. CERN: 16.86 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
CERN' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 1.3  Med: 16.50 Max: 22.9
Current: 16.86
1.3
22.9

More Statistics

Revenue(Mil) $4176
EPS $ 1.49
Beta1.14
Short Percentage of Float5.87%
52-Week Range $53.91 - 75.72
Shares Outstanding(Mil)342.10

Analyst Estimate

Dec15 Dec16 Dec17
Revenue(Mil) 4,425 5,026 5,604
EPS($) 2.04 2.36 2.72
EPS without NRI($) 2.04 2.36 2.72

Latest Earnings Webcast

» More Conference Calls

Business Description

Industry: Application Software » Health Information Services
Compare:CTRX, ATHN, MDRX, AH, QSII » details
Traded in other countries:CRE.Germany, CERN.Switzerland, 0R00.UK,
Cerner Corp is a Delaware corporation organized in 1986. The Company is a supplier of health care information technology and offers solutions and services that support the clinical, financial and operational needs of organizations. It has systems in 18,000 facilities throughout the world, including hospitals, physician practices, laboratories, ambulatory centers, behavioral health centers, cardiac facilities, radiology clinics, surgery centers, extended care facilities, retail pharmacies, and employer sites. Cerner solutions are offered on the unified Cerner Millennium architecture, a person-centric computing framework, which combines clinical, financial and management information systems. This architecture allows providers to securely access an individual's electronic health record at the point of care, and it organizes and delivers information to meet the specific needs of physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals and consumers. It has also created the Healthe IntentTM platform, a cloud-based platform that enables a new generation of solutions to leverage the increasing amount of data being captured as the health care industry is digitized. The Company also offers services, including implementation and training, remote hosting, operational management services, revenue cycle services, support and maintenance, health care data analysis, clinical process optimization, transaction processing, employer health centers, employee wellness programs and third party administrator services for employer-based health plans. It also offers hardware and devices, both from Cerner and as a reseller for third parties. The Company's main competitors in the health care solutions and services market include Allscripts Healthcare Solutions, Inc., Computer Programs and Systems, Inc., Epic Systems Corporation, GE Healthcare Technologies, Healthcare Management Systems, Inc., Healthland, Inc. , Computer Sciences Corporation, McKesson Corporation, Medical Information Technology, Inc., Siemens Medical Solutions Health Services Corporation, and Quadramed Corporation.
» More Articles for CERN

Headlines

Articles On GuruFocus.com
Stocks That Lost Their Positions in Jim Chanos' Portfolio Nov 27 2015 
Manning & Napier Advisors' Most Weighted Trades in Q2 2015 Jul 10 2015 
Weekly CEO Sells Highlight: Cerner Corp, Intel Corp, OM Group Inc, American Residential Properties I Jun 07 2015 
Soros Fund Eyes Potential In Noble Energy; Bridgewater Boosts Stake In Cerner May 18 2015 
Manning & Napier Trades in Each of its Top 10 Stakes in First Quarter May 08 2015 
2015 – The Year Of Health And Wellness Stocks Jan 19 2015 
CPSI: A Predictable And Undervalued Small Cap Dec 05 2014 
Manning & Napier Report Top Five Holdings Jul 18 2014 
Weekly 52-Week Highs Highlight: PCLN, NFLX, CERN, HPQ Feb 17 2014 
Weekly CFO Sells Highlight: FB, ZNGA, TRLA, EQT, CERN Aug 06 2013 

More From Other Websites
Cerner Growing Fast, But Health Care IT Rules Grow Faster Jan 26 2016
Cerner Trading Lower; CEO Confirms Ongoing Cancer Treatment Jan 25 2016
Healthcare IT firm Cerner's CEO diagnosed with cancer Jan 25 2016
Cerner CEO Patterson Says His Cancer Is ‘Curable,’ But Stock Falls Jan 25 2016
[$$] Cerner CEO to Undergo Treatment for Cancer Jan 25 2016
CERNER CORP /MO/ Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jan 25 2016
No Lion or Lamb, January Shows Up a Bear Jan 20 2016
4 Internet of Things (IoT) Stocks Poised for Solid Growth Jan 20 2016
The Last, Best Chance To Achieve Interoperability? Jan 18 2016
Cerner again teams up with KC-area startup Jan 14 2016
Infusion Express to provide convenient IV therapy services to Cerner health plan members in Kansas... Jan 14 2016
Jefferies Has 5 Top Growth Stocks to Buy After Horrible 2016 Start Jan 12 2016
Cerner to Release Fourth Quarter 2015 Earnings Results February 16 Jan 11 2016
Cerner to Release Fourth Quarter 2015 Earnings Results February 16 Jan 11 2016
Cerner upgraded by RBC Capital Mkts Jan 07 2016
5 stocks to watch Jan 06 2016
Cerner to Present at 2016 JP Morgan Healthcare Conference Jan 05 2016
Cerner to Present at JP Morgan Healthcare Conference Jan 05 2016
Cerner Corp. breached its 50 day moving average in a Bullish Manner : December 30, 2015 Dec 30 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK